Richard A.  Young net worth and biography

Richard Young Biography and Net Worth

Director of CAMP4 Therapeutics

Richard Young, PhD, is a Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology.

Dr. Young has served as an advisor to the National Institutes of Health, the World Health Organization, the Vatican, and numerous scientific societies and journals, and has founded and advised numerous companies in the biotechnology and pharmaceutical industry. His honors include membership in the National Academy of Sciences, the Chiron Corporation Biotechnology Research Award, Yale’s Wilbur Cross Medal, and recognition by Scientific American as one of the top 50 leaders in science, technology, and business (2006).

Dr. Young’s research focuses on gene regulatory circuitry in health and disease, with accomplishments ranging from the development of genome-wide analysis technologies to the discovery of the core regulatory circuitry of human embryonic stem cells. He joined Whitehead Institute and MIT in 1984 following postdoctoral research at Stanford University.

Dr. Young received his PhD in Molecular Biophysics and Biochemistry from Yale University and conducted his postdoctoral research at Stanford University.

What is Richard A. Young's net worth?

The estimated net worth of Richard A. Young is at least $715.74 thousand as of September 11th, 2025. Dr. Young owns 170,010 shares of CAMP4 Therapeutics stock worth more than $715,742 as of July 16th. This net worth estimate does not reflect any other investments that Dr. Young may own. Learn More about Richard A. Young's net worth.

How do I contact Richard A. Young?

The corporate mailing address for Dr. Young and other CAMP4 Therapeutics executives is 15635 Alton Parkway Suite 250, Irvine CA, 92618. CAMP4 Therapeutics can also be reached via phone at (949) 600-5600 and via email at [email protected]. Learn More on Richard A. Young's contact information.

Has Richard A. Young been buying or selling shares of CAMP4 Therapeutics?

Richard A. Young has not been actively trading shares of CAMP4 Therapeutics over the course of the past ninety days. Most recently, on Thursday, September 11th, Richard A. Young bought 15,151 shares of CAMP4 Therapeutics stock. The stock was acquired at an average cost of $1.65 per share, with a total value of $24,999.15. Following the completion of the transaction, the director now directly owns 170,010 shares of the company's stock, valued at $280,516.50. Learn More on Richard A. Young's trading history.

Who are CAMP4 Therapeutics' active insiders?

CAMP4 Therapeutics' insider roster includes Kurtis Binder (CFO), Jeffery Gardner (CEO), Kelly Gold (Chief Financial Officer), Josh Mandel-Brehm (President & Chief Executive Officer), Amir Nashat (Director), and Richard Young (Director). Learn More on CAMP4 Therapeutics' active insiders.

Are insiders buying or selling shares of CAMP4 Therapeutics?

During the last twelve months, CAMP4 Therapeutics insiders bought shares 7 times. They purchased a total of 5,588,885 shares worth more than $8,554,993.77. The most recent insider tranaction occured on September, 11th when Major Shareholder Polaris Management Co. Vii, L. bought 1,307,189 shares worth more than $1,999,999.17. Insiders at CAMP4 Therapeutics own 21.7% of the company. Learn More about insider trades at CAMP4 Therapeutics.

Information on this page was last updated on 9/11/2025.

Richard A. Young Insider Trading History at CAMP4 Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2025Buy15,151$1.65$24,999.15170,010View SEC Filing Icon  
See Full Table

Richard A. Young Buying and Selling Activity at CAMP4 Therapeutics

This chart shows Richard A Young's buying and selling at CAMP4 Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CAMP4 Therapeutics Company Overview

CAMP4 Therapeutics logo
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $4.21
Low: $4.17
High: $4.52

50 Day Range

MA: $4.28
Low: $3.92
High: $4.56

2 Week Range

Now: $4.21
Low: $1.32
High: $7.75

Volume

121,863 shs

Average Volume

319,609 shs

Market Capitalization

$218.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.1